Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Afrezza Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
Historical expansion is primarily due to the rising incidence of diabetes, coupled with the drawbacks of injectable insulin, the regulatory endorsement of inhaled insulin, patients’ desire for more convenient treatment options, and its prompt integration into adult diabetes care.
The anticipated growth during the forecast period is propelled by factors such as an expanding population affected by type 2 diabetes, the increasing adoption of inhalation-based drug delivery, and the broadening of target patient groups. Furthermore, improvements in pulmonary safety data and heightened awareness among physicians contribute to this growth.
Significant trends identified for the forecast period encompass the increasing acceptance of inhaled insulin therapies and a growing preference for needle-free approaches to diabetes management. Additionally, there is an intensified focus on controlling postprandial glucose, a wider availability of rapid-acting insulin alternatives, and improved patient adherence due to enhanced convenience.
Get A Free Sample Report With In-Depth Market Insights:
Afrezza Market Development Factors: What’s Supporting Demand?
The growing incidence of diabetes is anticipated to fuel the expansion of the afrezza market in the future. Diabetes is a long-term metabolic ailment characterized by elevated blood glucose levels, resulting from insufficient insulin generation, impaired insulin function, or both. The rise in diabetes cases is linked to escalating obesity rates, sedentary habits, unhealthy eating patterns, an aging population, increasing urbanization, genetic susceptibility, and improved detection and diagnosis of the condition. Afrezza is vital for treating diabetes because it quickly manages post-meal blood sugar surges, thereby averting complications and ensuring effective glucose regulation. For example, in March 2024, information from the Office for Health Improvement and Disparities, a UK government department, revealed that in March 2023, the percentage of individuals with type 1 diabetes in England receiving 8 care processes at GP practices involved in the NDA increased to 43.8%, up from 35.2% in 2022. Thus, the rising prevalence of diabetes is a significant catalyst for the afrezza market.
Afrezza Market Segmentation And Category Overview
The afrezza market covered in this report is segmented –
1) By Indication: Type 1 Diabetes, Type 2 Diabetes
2) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Specialty Pharmacies
3) By End User: Adult Patients, Geriatric Patients
Afrezza Market Transformation Trends: What Innovations Are Driving Change?
Major companies in the Afrezza market are focused on developing technically advanced products through detailed studies concerning the product and diabetes. Afrezza is utilized to manage Type 1 Diabetes with insulin inhalers. For instance, in June 2023, MannKind Corporation, a US-based biopharmaceutical company, initiated the INHALE-3 study, which is a clinical trial designed to address a crucial unmet need for adults with Type 1 Diabetes. The trial spans 17 weeks and includes a 13-week extension phase, allowing researchers to evaluate outcomes further over an extended period. INHALE-3 is a randomized, controlled study aimed at assessing innovative treatment approaches that could improve daily disease management and overall patient well-being. By launching this trial, MannKind seeks to generate meaningful clinical insights that may support more effective therapeutic options for individuals living with Type 1 Diabetes.
Afrezza Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the afrezza market are Mannkind Corporation
View The Full Afrezza Market Report:
Afrezza Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the afrezza market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afrezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









